3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
5
Rhabdoid Tumor
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Sarcoma, Synovial
3
Lymphoma, Non-Hodgkin
3
Lymphoma, B-Cell
3
Wilms Tumor
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Mesothelioma
2
Medulloblastoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Glioma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Inhibition, Psychological
1
Hodgkin Disease
1
Interventions
Gemcitabine
47
Cisplatin
32
pembrolizumab
28
Paclitaxel
13
Docetaxel
13
avelumab
12
Mitomycin
12
atezolizumab
11
Nivolumab
11
Cystectomy
10
Carboplatin
9
durvalumab
7
Sunitinib
7
apaziquone
6
Doxorubicin
6
BCG Vaccine
6
5-aminolevulinic acid hexyl ester
6
Vinblastine
5
Radiation
5
Platinum
5
Methotrexate
5
Magnetic Resonance Spectroscopy
5
Albumin-Bound Paclitaxel
5
Taxes
4
Standard of Care
4
Sorafenib
4
Radiotherapy
4
Fluorouracil
4
Erlotinib Hydrochloride
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urinary Bladder Neoplasms
×
tazemetostat
×
Clear all
No trials found.